跳至主要内容
临床试验/NCT06216197
NCT06216197已完成不适用

Dexmedetomidine Versus Fentanyl as an Adjuvant to Bupivacaine in Saddle Block for Various Anal Surgeries: A Correlative Randomized Trial

Zulekha Hospitals1 个研究点 分布在 1 个国家目标入组 58 人开始时间: 2021年4月3日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
58
试验地点
1
主要终点
the duration until the first call for analgesia

研究概览

简要总结

Dexmedetomidine is recommended over fentanyl as adjunctive medication to bupivacaine for saddle block spinal anesthesia in anal surgeries and procedures.

详细描述

Objectives: A saddle spinal block is a viable choice for anal surgeries. This technique effectively maintains balanced hemodynamics, and fast recovery, and prevents irrelevant motor blocks in both limbs.

Methods: Fifty-eight adult patients were categorized into two groups. Group FENT, consisting of 29 patients, underwent a saddle block with hyperbaric bupivacaine (2.5 ml) combined with fentanyl (0.5 ml; 25 μg). The DEX Group, consisting of 29 patients, received 2.5 ml of hyperbaric bupivacaine mixed with dexmedetomidine (10 μg; 0.5 ml). Continuous monitoring of HR and SpO2 was conducted. Evaluation of sensory blockage and the motor block was done utilizing the Bromage scale. Following surgery, assessments were conducted. Pain in the ward and PACU was determined utilizing the visual analog scale (VAS).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
Single (Investigator)

盲法说明

The subjects were randomly categorized into two groups utilizing random numbers generated by computer software. A sealed envelope (containing the allocation numbers of groups) was opened at the time of patient enrollment.

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • both sexes
  • aged between 20 and 60
  • classified as II & ASA-I
  • scheduled for elective anal surgeries

排除标准

  • subjects who refused to participate
  • uncontrolled hypertension
  • BMI > 30 kg/m2
  • heart failure (class IV or III) based on the New York Heart Association (NYHA)
  • uncorrected coagulopathy
  • any study's drug allergy
  • drug abuse
  • neuropathy
  • any spinal anesthesia contraindication (such as infection or a pelvic fracture)

研究组 & 干预措施

The FENT Group

Other

Group FENT, consisting of 29 patients, underwent a saddle block with hyperbaric bupivacaine (2.5 ml) combined with fentanyl (0.5 ml; 25 μg).

干预措施: FENT group (Drug)

The DEX Group

Other

The DEX Group, consisting of 29 patients, received 2.5 ml of hyperbaric bupivacaine mixed with dexmedetomidine (10 μg; 0.5 ml).

干预措施: DEX group (Drug)

结局指标

主要结局

the duration until the first call for analgesia

时间窗: 20 months

the duration until the first call for analgesia

次要结局

  • the duration from spinal injection until reaching the maximal sensory level(20 months)
  • the duration needed for sensory regression to occur over two spinal segments from the maximal sensory level(20 months)
  • the time required for sensory regression until reaching the S1 level (from the maximal sensory level)(20 months)
  • the duration from injection to achieving Bromage 0, the total tramadol consumption (until the first 24 hours)(20 months)
  • side effects occurrences(20 months)

研究者

发起方
Zulekha Hospitals
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验